Calcific aortic stenosis: an update

Lindroos M et al. (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21: 1220–1225

Ross J Jr and Braunwald E (1968) Aortic stenosis. Circulation 38 (Suppl 1): S61–S67

Rahimtoola SH (1991) Perspectives on valvular heart disease: update II. In An era in cardiovascular medicine, 45–70 (Eds Knoebel SB and Dack S) New York: Elsevier

Roberts WC and Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111: 920–925

Stewart BF et al. (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29: 630–634

Aronow WS et al. (1987) Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 59: 998–999

Otto CM et al. (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341: 142–147

Pohle K et al. (2001) Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104: 1927–1932

O'Brien KD et al. (1996) Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 16: 523–532

Olsson M et al. (1999) Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19: 1218–1222

Otto CM et al. (1994) Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation 90: 844–853

Sprecher DL et al. (1984) Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 54: 20–30

Rajamannan NM et al. (2003) Hypercholesterolemic aortic-valve disease. N Engl J Med 349: 717–718

Rajamannan NM et al. (2001) Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 10: 371–374

Rajamannan NM et al. (2002) Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105: 2660–2665

Garg V et al. (2005) Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270–274

Ortlepp JR et al. (2001) The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85: 635–638

Avakian SD et al. (2001) Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis. Clin Genet 60: 381–384

O'Brien KD et al. (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92: 2163–2168

Liebe V et al. (2006) Coagulation activation is associated with interleukin-6 plasma levels in patients with mechanical prosthetic heart valves. In Vivo 20: 427–430

Galante A et al. (2001) C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 38: 1078–1081

Soini Y et al. (2003) Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol 34: 756–763

Rajamannan NM et al. (2005) Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 111: 3296–3301

Jian B et al. (2003) Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 75: 457–465

Kaden JJ et al. (2005) Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med 16: 869–872

O'Brien KD et al. (2002) Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106: 2224–2230

Chalajour F et al. (2004) Angiogenic activation of valvular endothelial cells in aortic valve stenosis. Exp Cell Res 298: 455–464

Mohler ER et al. (1991) Development and progression of aortic valve stenosis: atherosclerosis risk factors—a causal relationship? A clinical morphologic study. Clin Cardiol 14: 995–999

Rajamannan NM et al. (2003) Calcific aortic stenosis: from bench to the bedside—emerging clinical and cellular concepts. Heart 89: 801–805

Rajamannan NM et al. (2003) Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107: 2181–2184

Mohler ER III et al. (2001) Bone formation and inflammation in cardiac valves. Circulation 103: 1522–1528

Caira FC et al. (2006) Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47: 1707–1712

Kaden JJ et al. (2004) Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 13: 560–566

Mohler ER III et al. (1997) Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17: 547–552

Mathieu P et al. (2005) Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis 14: 353–357

Rahimtoola SH (2006) The year in valvular heart disease. J Am Coll Cardiol 47: 427–439

Johnson ML and Rajamannan N (2006) Diseases of Wnt signaling. Rev Endocr Metab Disord 7: 41–49

Rajamannan NM et al. (2005) Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112 (Suppl 9): I229–I234

Shao JS et al. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210–1220

Rosenhek R et al. (2000) Predictors of outcome in severe asymptomatic aortic stenosis. N Engl J Med 343: 611–617

O'Brien KD et al. (2004) Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 52: 185–191

O'Brien KD et al. (2005) Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 165: 858–862

Rajamannan NM et al. (2005) Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91: 806–810

American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114: e84–e231

Aronow WS et al. (2001) Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 88: 693–695

Novaro GM et al. (2001) Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104: 2205–2209

Bellamy MF et al. (2002) Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 40: 1723–1730

Shavelle DM et al. (2002) HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359: 1125–1126

Cowell SJ et al. (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389–2397

Moura LM et al. (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49: 554–561

Rossebo A et al. (2003) 3P-0870 Design of the Simvastatin and Szetimide in Aortic Stenosis (SEAS) Study [abstract]. Atheroscler Suppl 4: 253

Rahimtoola SH (2004) Aortic valve disease. In Hurst's The Heart Manual of Cardiology, 1643–1679 (Eds Fuster V et al.) New York: McGraw-Hill Medical

Wood P (1956) Aortic stenosis. In Diseases of the Heart and Circulation, 568–583 (Ed Wood P) London: Eyre and Spootiswoode

Beauchesne LM et al. (2003) Temporal variations in effective orifice area during ejection in patients with valvular aortic stenosis. J Am Soc Echocardiogr 16: 958–964

Leatham A (1951) The phonocardiogram of aortic stenosis. Br Heart J 13: 153–158

Rahimtoola SH (1999) “Prophylactic” valve replacement for mild aortic valve disease at time of surgery for other cardiovascular disease?...No. J Am Coll Cardiol 33: 2009–2015

Rahimtoola SH (2000) Severe aortic stenosis with low systolic gradient: the good and bad news. Circulation 101: 1892–1894

Monin JL et al. (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108: 319–324

Griffith MJ et al. (1989) Inaccuracies in using aortic valve gradients alone to grade severity of aortic stenosis. Br Heart J 62: 372–378

Bucciarelli-Ducci C et al. (2006) Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease. Curr Probl Cardiol 31: 128–168

Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–221

Rahimtoola SH et al. (2006) Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 47: 978–980

Rahimtoola SH (2003) Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41: 893–904

Rahimtoola SH (2005) The year in valvular heart disease. J Am Coll Cardiol 45: 111–12255